发明名称 1,2-di(cyclic)substituted benzene compounds
摘要 A compound represented by the following general formula (1) or (100), a salt thereof or a hydrate of the foregoing has excellent cell adhesion inhibitory action or cell infiltration inhibitory action, and is useful as a therapeutic or prophylactic agent for various inflammatory diseases and autoimmune diseases associated with adhesion and infiltration of leukocytes, such as inflammatory bowel disease (particularly ulcerative colitis or Crohn's disease), irritable bowel syndrome, rheumatoid arthritis, psoriasis, multiple sclerosis, asthma and atopic dermatitis. wherein R10 represents optionally substituted cycloalkyl, etc., R20-23 represent hydrogen, alkyl, alkoxy, etc., R30-32 represent hydrogen, alkyl, oxo, etc., and R40 represents optionally substituted alkyl, etc.
申请公布号 US2007112002(A1) 申请公布日期 2007.05.17
申请号 US20040581591 申请日期 2004.12.24
申请人 KAWAHARA TETSUYA;KOTAKE MAKOTO;YONEDA NAOKI;HIROTA SHINSUKE;OHKURO MASAYOSHI 发明人 KAWAHARA TETSUYA;KOTAKE MAKOTO;YONEDA NAOKI;HIROTA SHINSUKE;OHKURO MASAYOSHI
分类号 A61K31/5377;A61K31/381;A61K31/382;A61K31/40;A61K31/407;A61K31/4418;A61K31/451;A61K31/452;A61K31/4525;A61K31/495;A61K31/496;A61K31/4965;A61K31/5375;A61K31/55;A61P1/00;A61P1/04;A61P11/06;A61P17/00;A61P17/06;A61P19/02;A61P37/06;A61P37/08;A61P43/00;C07D207/06;C07D207/12;C07D207/273;C07D207/325;C07D211/14;C07D211/16;C07D211/18;C07D211/38;C07D211/42;C07D211/46;C07D211/56;C07D211/58;C07D211/62;C07D211/70;C07D211/72;C07D213/36;C07D213/64;C07D213/75;C07D233/04;C07D241/18;C07D257/04;C07D261/08;C07D265/30;C07D265/32;C07D271/10;C07D277/28;C07D295/02;C07D295/03;C07D295/067;C07D295/073;C07D295/08;C07D295/088;C07D295/096;C07D295/12;C07D295/135;C07D295/14;C07D295/15;C07D295/155;C07D295/18;C07D295/205;C07D307/52;C07D309/04;C07D309/14;C07D333/20;C07D335/02;C07D403/02;C07D405/12;C07D413/02;C07D413/12;C07D487/08 主分类号 A61K31/5377
代理机构 代理人
主权项
地址